EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 3
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Maintaining Compliance Throughout a Manufacturing Move or Merger
Uncategorized

Maintaining Compliance Throughout a Manufacturing Move or Merger

It’s easy to underestimate the regulatory considerations during a move or consolidation of manufacturing operations, and this could have serious consequences, includi...
25 October 2018 Uncategorized
Continue Reading →
Landscape of Early-phase Oncology Studies in the Netherlands
Volume 10 Issue 5

Landscape of Early-phase Oncology Studies in the Netherlands

The Netherlands has been a natural favourite for conducting clinical research with the Dutch healthcare system ranking among the best in Europe, the high level of edu...
25 October 2018 Volume 10 Issue 5
Continue Reading →
The Journey to Clinic and Beyond
Volume 10 Issue 5

The Journey to Clinic and Beyond

The formulation of a candidate drug for first in human (FIH) trials is of great importance – how a pharmaceutical company chooses to approach this challenge can ultim...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Clinical Development in Rare Diseases: Idiopathic Pulmonary Fibrosis
Volume 10 Issue 5

Clinical Development in Rare Diseases: Idiopathic Pulmonary Fibrosis

IPF is a rare disease, in which patients are most often affected from middle age, and its manifestation is characterised by severe, irreversible interstitial fibrosis...
25 October 2018 Volume 10 Issue 5
Continue Reading →
The Evolving Clinical Trial Landscape in Amyotrophic Lateral Sclerosis
Volume 10 Issue 5

The Evolving Clinical Trial Landscape in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis is a neurodegenerative disorder affecting predominantly central and peripheral motor neurons, resulting in progressive weakness and atro...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Open to Interpretation
Volume 10 Issue 5

Open to Interpretation

The emphasis on patient-reported outcomes and clinician reports is growing in life sciences R&D, so it follows that these sources of feedback must be recorded con...
25 October 2018 Volume 10 Issue 5
Continue Reading →
The Modality Menu: Making the Right Choice for Your eCOA Study
Volume 10 Issue 5

The Modality Menu: Making the Right Choice for Your eCOA Study

The exponential growth of technology has opened up a world of opportunities for clinical research. Electronic clinical outcome assessment (eCOA) solutions, which allo...
25 October 2018 Volume 10 Issue 5
Continue Reading →
The Role of Interactive Response Technology (IRT) in Clinical Trial Supply
Volume 10 Issue 5

The Role of Interactive Response Technology (IRT) in Clinical Trial Supply

Increasingly elaborate international clinical trials demand a smart, streamlined approach from supply partners and better collaboration with sponsors. In this environ...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Cyber Risks in the Life Sciences Industry
Volume 10 Issue 5

Cyber Risks in the Life Sciences Industry

Pharmaceutical, research, clinical trials and similar organisations all rely on technology to conduct their daily work, share information and communicate, so any comp...
25 October 2018 Volume 10 Issue 5
Continue Reading →
This is the Dawning of the Age of the Estimand
Volume 10 Issue 5

This is the Dawning of the Age of the Estimand

In recent months, the term ‘estimand’ has started to appear in clinical trial protocols and reports. The term itself is simple enough, meaning ‘that which is to be es...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte